Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Henk de Vrieze"'
Autor:
Lotte A van de Stadt, Mieke C. Brouwer, Ninotska I. L. Derksen, Henk de Vrieze, Diana Wouters, Theo Rispens, Dirkjan van Schaardenburg, Gertjan Wolbink
Publikováno v:
Arthritis & Rheumatology. 66:1133-1140
Objective In rheumatoid arthritis (RA), autoantibodies such as anti–citrullinated protein antibodies (ACPAs) develop in response to neoepitopes that are formed under conditions of chronic inflammation. These autoantibodies may subsequently be fragm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::225fd3f76a77da2783dfe7644dd6a882
https://doi.org/10.1002/art.38335
https://doi.org/10.1002/art.38335
Autor:
Els R. de Groot, Theo Rispens, Diana Wouters, S.O. Stapel, Lucien A. Aarden, Henk de Vrieze, Gerrit Jan Wolbink
Publikováno v:
Journal of immunological methods, 375(1-2), 93-99. Elsevier
Rheumatoid factors are antibodies directed against IgG that may confound immunogenicity testing for therapeutic monoclonal antibodies. We developed antigen-binding assays to monitor anti-drug-antibody (ADA) responses against infliximab and adalimumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84a43522cc3ee0105db3b359679ae0d4
https://pure.amc.nl/en/publications/antibodies-to-constant-domains-of-therapeutic-monoclonal-antibodies-antihinge-antibodies-in-immunogenicity-testing(4e499adf-3e36-44a0-abef-59ab0adef67d).html
https://pure.amc.nl/en/publications/antibodies-to-constant-domains-of-therapeutic-monoclonal-antibodies-antihinge-antibodies-in-immunogenicity-testing(4e499adf-3e36-44a0-abef-59ab0adef67d).html
Autor:
Henk de Vrieze, Joep Killestein, Els R. de Groot, G.J. Wolbink, Theo Rispens, Diana Wouters, M. Hart, Lucien A. Aarden
Publikováno v:
Journal of immunological methods, 372(1-2), 196-203. Elsevier
Journal of Immunological Methods, 372(1-2), 196-203. Elsevier
Hart, M H, de Vrieze, H, Wouters, D, Wolbink, G J, Killestein, J, Groot, E R, Aarden, L A & Rispens, T 2011, ' Differential effect of drug interference in immunogenicity assays ', Journal of Immunological Methods, vol. 372, no. 1-2, pp. 196-203 . https://doi.org/10.1016/j.jim.2011.07.019
Journal of Immunological Methods, 372(1-2), 196-203. Elsevier
Hart, M H, de Vrieze, H, Wouters, D, Wolbink, G J, Killestein, J, Groot, E R, Aarden, L A & Rispens, T 2011, ' Differential effect of drug interference in immunogenicity assays ', Journal of Immunological Methods, vol. 372, no. 1-2, pp. 196-203 . https://doi.org/10.1016/j.jim.2011.07.019
The presence of anti-drug antibodies (ADA) in adalimumab-treated patients is associated with reduced serum adalimumab levels and a lower clinical response. Currently, there is no standard for measurement of anti-drug antibodies and many factors influ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4f1ac4f8bd7846433cf21b229222424
https://pure.amc.nl/en/publications/differential-effect-of-drug-interference-in-immunogenicity-assays(80fb8444-2692-4fb8-8919-fd680cca20c2).html
https://pure.amc.nl/en/publications/differential-effect-of-drug-interference-in-immunogenicity-assays(80fb8444-2692-4fb8-8919-fd680cca20c2).html
Autor:
Mirjam K. de Vries, Ben A. C. Dijkmans, S.O. Stapel, Henk de Vrieze, J Christiaan van Denderen, Gerrit Jan Wolbink, Irene E. van der Horst-Bruinsma, Lucien A. Aarden
Publikováno v:
Annals of the rheumatic diseases, 66(9), 1252-1254. BMJ Publishing Group
OBJECTIVES: Correlation of serum trough infliximab levels and antibodies to infliximab (anti-infliximab) with clinical response in ankylosing spondylitis. METHODS: In accordance with the international ASsessment in Ankylosing Spondylitis (ASAS) conse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5d567c8d74b86cf012c5568e903f7b3
https://pubmed.ncbi.nlm.nih.gov/17472991
https://pubmed.ncbi.nlm.nih.gov/17472991